FASENRA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0310-1830
  • Package NDC 0310-1830-30
  • Package NDC 0310-1830-85
  • Application number BLA761070
  • SPL ID b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe
  • SPL set ID da6aca1a-19ed-44a4-abb7-696c7d58b784
  • UNII 71492GE1FX
  • RxCUI 1989104
  • RxCUI 1989109
  • RxCUI 2205632
  • RxCUI 2205634
  • RxCUI 2679499
  • RxCUI 2679502

What the source publishes

Labeler
AstraZeneca Pharmaceuticals LP
Active ingredients
Benralizumab
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0310-1830_b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe
{
  "name": "FASENRA",
  "splId": "b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe",
  "labels": [
    {
      "setId": "da6aca1a-19ed-44a4-abb7-696c7d58b784",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da6aca1a-19ed-44a4-abb7-696c7d58b784",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da6aca1a-19ed-44a4-abb7-696c7d58b784"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "AstraZeneca Pharmaceuticals LP",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 CARTRIDGE in 1 CARTON (0310-1830-30)  / 1 mL in 1 CARTRIDGE",
      "package_ndc": "0310-1830-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191004"
    },
    {
      "sample": true,
      "description": "1 CARTRIDGE in 1 CARTON (0310-1830-85)  / 1 mL in 1 CARTRIDGE",
      "package_ndc": "0310-1830-85",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191004"
    }
  ],
  "productId": "0310-1830_b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "0310-1830",
  "deaSchedule": null,
  "genericName": "Benralizumab",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BENRALIZUMAB",
      "strength": "30 mg/mL"
    }
  ],
  "applicationNumber": "BLA761070",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20191004",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000193803",
      "N0000193802"
    ],
    "unii": [
      "71492GE1FX"
    ],
    "rxcui": [
      "1989104",
      "1989109",
      "2205632",
      "2205634",
      "2679499",
      "2679502"
    ],
    "spl_set_id": [
      "da6aca1a-19ed-44a4-abb7-696c7d58b784"
    ],
    "pharm_class_epc": [
      "Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"
    ],
    "pharm_class_moa": [
      "Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"
    ],
    "manufacturer_name": [
      "AstraZeneca Pharmaceuticals LP"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0310-1830_b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe"